Mitotherapeutix
Business Services · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
400 Farmington Ave, Farmington, Connecti...Phone Number
(203) 676-1709Website
www.mitotherapeutix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Mitotherapeutix
Mitotherapeutix, LLC specializes in developing siRNA-based drugs that leverage advancements in RNA chemistry to target challenging disease targets. Their primary focus is on a novel protein that regulates mitochondrial activity, which is crucial for cellular energy production. By inhibiting this negative regulator, they aim to enhance metabolism and improve treatment outcomes for various diseases. The company's innovative approach opens up possibilities for creating therapies that address a wide range of health conditions.Explore more
Mitotherapeutix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mitotherapeutix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Mitotherapeutix, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Mitotherapeutix is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Mitotherapeutix has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Mitotherapeutix has new funding data
Congratulate Masked Content for being promoted to Masked Content at Mitotherapeutix
Click to see if Mitotherapeutix had a recent Job posting/layoffs
Product Launch: Get notified when Mitotherapeutix launches new products
Earning: See what the market has to say on Mitotherapeutix recently announced quarterly report
Recommended Actions
Find VP level buyers at Mitotherapeutix
Find 3 more new buyers
Compare Similar Companies to Mitotherapeutix
Compare insights from companies similar to Mitotherapeutix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mitotherapeutix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Mitotherapeutix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Mitotherapeutix.
Mitotherapeutix Tech Stack
A closer look at the technologies used by Mitotherapeutix
See more technologies
Mitotherapeutix News & Media
Mitotherapeutix Announces Positive Results from Pre-Clinical Liver...
siRNA Drug Candidates Suppress Novel NASH Target MCJ (PRWeb September 24, 2020) Read the full story at https://www.prweb.com/releases/mitotherapeutix_announces_positive_results_from_pre_clinical_liver_biopsy_study_in_cynomolgus_monkeys/prweb17420856.htm
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Mitotherapeutix
Sign Up For FreeTo access detailed company insights
Mitotherapeutix, LLC specializes in developing siRNA-based drugs that leverage advancements in RNA chemistry to target challenging disease targets. Their primary focus is on a novel protein that regulates mitochondrial activity, which is crucial for cellular energy production. By inhibiting this negative regulator, they aim to enhance metabolism an... Read More
